MOESM2 of Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity

Chitapanarux, Imjai; Klunklin, Pitchayaponne; Pinitpatcharalert, Attapol; Sripan, Patumrat; Tharavichitkul, Ekkasit; Nobnop, Wannapha; Onchan, Wimrak; Chakrabandhu, Somvilai; Jia-Mahasap, Bongkot; Euathrongchit, Juntima; Wannasopha, Yutthaphan; Srisuwan, Tanop

doi:10.6084/m9.figshare.9980363.v1

13014_2019_1378_MOESM2_ESM.docx (16.77 kB)

MOESM2 of Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity

journal contribution

posted on 2019-10-15, 05:48 authored by Imjai Chitapanarux, Pitchayaponne Klunklin, Attapol Pinitpatcharalert, Patumrat Sripan, Ekkasit Tharavichitkul, Wannapha Nobnop, Wimrak Onchan, Somvilai Chakrabandhu, Bongkot Jia-Mahasap, Juntima Euathrongchit, Yutthaphan Wannasopha, Tanop Srisuwan

Additional file 2: Table S2. A comparison of late toxicity between CF-PMRT and HF-PMRT.

Funding

Faculty of Medicine, Chiang Mai University

History

Usage metrics

Keywords

Long-term Outcome Toxicity Conventional Hypofractionated Postmastectomy radiotherapy

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

MOESM2 of Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity

Funding

Faculty of Medicine, Chiang Mai University

History

Usage metrics

Categories

Keywords

Licence

Exports